Cargando…
Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality
Dalbavancin is a new antibiotic that is effective against Gram-positive microorganisms, including methicillin-resistant Staphylococci, and offers the possibility of administering intravenous therapy once weekly in an ambulatory setting. We conducted a multicenter observational case-control study, co...
Autores principales: | de Pablo-Miró, Mar, Pujol-Ruiz, Sergi, Iftimie, Simona, Arenas-Miras, María del Mar, López-Montesinos, Inmaculada, Duran-Jordà, Xavier, Anglès, Albert, Grau, Santiago, Horcajada, Juan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614661/ https://www.ncbi.nlm.nih.gov/pubmed/34827234 http://dx.doi.org/10.3390/antibiotics10111296 |
Ejemplares similares
-
DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2019) -
Glycopeptide Resistance in Gram-Positive Cocci: A Review
por: Sujatha, S., et al.
Publicado: (2012) -
Post-neurosurgical meningitis; gram negative bacilli vs. gram positive cocci
por: Zeinalizadeh, Mehdi, et al.
Publicado: (2022) -
A NOTE ON THE BEHAVIOR OF THE SAPROPHYTIC COCCI WITH REGARD TO GRAM'S STAIN
por: Kligler, I. J.
Publicado: (1913) -
Clinical and Economic Impact of Community-Onset Urinary Tract Infections Caused by ESBL-Producing Klebsiella pneumoniae Requiring Hospitalization in Spain: An Observational Cohort Study
por: Rozenkiewicz, Dawid, et al.
Publicado: (2021)